Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease

Alma Zecevic, Deepa Sampath, Brett Ewald, Rong Chen, William Wierda, William Plunkett

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease'. Together they form a unique fingerprint.

Medicine & Life Sciences